Impaired Akt phosphorylation in insulin-resistant human muscle is accompanied by selective and heterogeneous

K T Tonks1, Y Ng, S Miller

  • 1Diabetes and Obesity Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, 2010 NSW, Australia.

Diabetologia
|January 25, 2013
PubMed
Abstract

Insights

Muscle insulin resistance in type 2 diabetes involves the Akt pathway. Obesity, not insulin resistance, impairs AS160 phosphorylation, while FOXO gene expression is downregulated, suggesting pathway hyperactivation.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Metabolic Syndrome Research

Background:

  • Muscle insulin resistance is an early defect in type 2 diabetes, linked to the phosphoinositide 3-kinase/Akt signaling network.
  • The distinct roles of obesity and insulin resistance in disrupting this pathway remain unclear.

Purpose of the Study:

  • To investigate the differential effects of obesity and insulin resistance on the Akt signaling pathway in muscle.
  • To understand the relationship between insulin sensitivity, adiposity, and specific Akt pathway components.

Main Methods:

  • Utilized phosphospecific antibodies to examine Akt signaling in muscle tissue from lean, overweight/obese, and type 2 diabetic individuals.
  • Employed a hyperinsulinemic-euglycemic clamp to assess insulin action before and during the clamp.

Main Results:

  • Insulin-stimulated Akt phosphorylation (Thr309, Ser474) strongly correlated with whole-body insulin sensitivity.
  • Impaired phosphorylation of Akt substrate of 160 kDa (AS160) was linked to adiposity, independent of insulin sensitivity.
  • Insulin sensitivity and obesity did not correlate with defects in insulin-dependent forkhead box O (FOXO) phosphorylation.
  • Downregulation of FOXO-targeted genes was observed in insulin-resistant individuals, despite normal FOXO phosphorylation.

Conclusions:

  • Akt signaling exhibits non-linearity, with distinct responses to insulin and obesity.
  • The pathway from Akt to glucose transport is complex and not fully elucidated.
  • Insulin-spared pathways like FOXO may become hyperactivated due to basal hyperinsulinemia in insulin resistance.
  • This hyperactivation of specific Akt pathway components could contribute to metabolic syndrome features.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...